Limitations of biopsy-based transcript diagnostics to detect T-cell-mediated allograft rejection
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfae147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Lukas Weidmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Zurich, Department of Nephrology, Zurich, Switzerland. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation, T-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USZ Foundation, Baugarten Foundation, SwissLife Foundation.
Abstract (Originalsprache)
Background
Isolated tubulitis, borderline changes and isolated arteritis suspicious for histologic T-cell-mediated rejection (hTCMR) remain findings of uncertain significance. Although the Molecular Microscope Diagnostics System (MMDx) has not been trained on those lesions, it was suggested that MMDx might reclassify a subgroup to molecular TCMR (mTCMR).
Methods
In this single-center cohort of 326 consecutive, unselected kidney allograft biopsies assessed by histology and MMDx, we analyzed 249 cases with isolated tubulitis (i0, t1–3, v0; n = 101), borderline changes (according to Banff 2022, v0; n = 9), isolated arteritis (no borderline, v1; n = 37), no inflammation (i0, t0, v0; n = 67) and a positive control cohort (hTCMR, n = 27; mixed histologic rejection, n = 8; both according to Banff 2022; total n = 35). The first three groups were summarized as TCMR-suspicion (n = 147). Subcategorization included the presence and absence of microvascular inflammation (MVI); g+ptc ptc ≥2. Molecular rejection rates and differentiation were investigated.
Results
Molecular rejection rates were 37/147 cases (25.2%; 32 with MVI) in TCMR-suspicion, 6/67 (9%; 4 with MVI) in no inflammation and 30/35 (85.7%; 19 with MVI) in the positive control cohort. Molecular antibody-mediated rejection (mAMR) was present in 39/73 (53.4%) of cases. The presence of donor-specific antibodies at the time of the biopsy was high (127/249, 51%). Only 3 mAMR/TCMR and 0 pure mTCMR cases were detected in TCMR-suspicion and no inflammation, compared with 12 mAMR/TCMR and 10 mTCMR cases in the positive control cohort (P < .001). Even though the TCMR-specific molecular (Classifier) score differentiated between TCMR-suspicion and no inflammation (P = 0.005), rejection phenotype scores (R2 and R3) did not (P = .157 and .121).
Conclusions
MMDx did not identify pure mTCMR among isolated tubulitis, borderline changes or isolated arteritis, likely due to low sensitivity for TCMR lesions. However, it identified mAMR or mAMR/TCMR, especially in cases with MVI. Subthreshold findings remain to be further studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospital Zurich, Department of Nephrology, Zurich, Switzerland.
- University Hospital Zurich, Department of Pathology and Molecular Pathology, Zurich, Switzerland.
ORCID-Profile: Lukas Weidmann, Elena Rho, Thomas Schachtner
Förderung
- USZ Foundation
- Baugarten Foundation
- SwissLife Foundation
Zitieren
APA
Weidmann, L., Harmacek, D., Castrezana Lopez, K., Helmchen, B. M., Gaspert, A., Korach, R., Bortel, N., Schmid, N., von Moos, S., Rho, E., & Schachtner, T. (2025). Limitations of biopsy-based transcript diagnostics to detect T-cell-mediated allograft rejection. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae147
Vancouver
Weidmann L, Harmacek D, Castrezana Lopez K, Helmchen BM, Gaspert A, Korach R, et al. Limitations of biopsy-based transcript diagnostics to detect T-cell-mediated allograft rejection. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfae147
BibTeX
@article{Weidmann2025,
author = {Weidmann, Lukas and Harmacek, Dusan and Castrezana Lopez, Kai and Helmchen, Birgit Maria and Gaspert, Ariana and Korach, Raphael and Bortel, Nicola and Schmid, Nicolas and von Moos, Seraina and Rho, Elena and Schachtner, Thomas},
title = {Limitations of biopsy-based transcript diagnostics to detect T-cell-mediated allograft rejection},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfae147}
}
EUVIMED